Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$520K Sell
1,369
-1,154
-46% -$315K ﹤0.01% 681
2026
Q1
$406K Sell
2,523
-2,801
-53% -$463K ﹤0.01% 791
2025
Q4
$584K Sell
5,324
-4,006
-43% -$341K ﹤0.01% 704
2025
Q3
$464K Buy
+9,330
New +$454K ﹤0.01% 806
2024
Q2
Sell
-16,872
Closed -$645K 975
2024
Q1
$645K Buy
16,872
+1,659
+11% +$64.5K ﹤0.01% 785
2023
Q4
$684K Buy
+15,213
New +$670K ﹤0.01% 745
2022
Q2
Sell
-29,293
Closed -$2.07M 1111
2022
Q1
$2.07M Buy
29,293
+11,118
+61% +$999K 0.01% 839
2021
Q4
$2.31M Buy
18,175
+4,786
+36% +$678K 0.01% 839
2021
Q3
$1.8M Buy
+13,389
New +$1.6M 0.01% 769
2021
Q2
Sell
-14,391
Closed -$1.22M 982
2021
Q1
$1.22M Sell
14,391
-1,830
-11% -$172K 0.01% 816
2020
Q4
$1.5M Sell
16,221
-13,150
-45% -$1.1M 0.01% 765
2020
Q3
$2.28M Sell
29,371
-2,459
-8% -$196K 0.01% 703
2020
Q2
$2.29M Sell
31,830
-60,480
-66% -$3.4M 0.01% 707
2020
Q1
$4.11M Buy
+92,310
New +$4.38M 0.03% 452

Other funds holding VICR

Aviva's VICR Position: Q2 2026 in Review

Aviva reduced its Vicor (VICR) stake by 46% in Q2 2026, selling an estimated $315K and leaving 1,369 shares worth $520K. The position accounts for ﹤0.01% of the portfolio, ranked #681.

Aviva first reported a position in VICR in Q1 2020 and has held it in 14 quarters since. The position peaked at $4.11M in Q1 2020. 514 funds tracked by Wall St. Rank hold VICR as of Q2 2026.

  • Aviva held 1,369 shares of Vicor worth $520K as of Q2 2026.
  • Aviva sold 1,154 Vicor shares in Q2 2026, an estimated $315K.
  • Vicor made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #681 holding.
  • Aviva first reported a position in Vicor in Q1 2020 and has held it in 14 quarters since.
  • Aviva's Vicor position peaked at $4.11M in Q1 2020.
  • 514 funds tracked by Wall St. Rank held Vicor as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.